L'Utile Operativo Cambiamento Data
AstraZeneca USD 4.66B 1.5B 2026-09
Autolus Therapeutics Ltd USD -59.51M 12.95M 2026-03
Hikma Pharmaceutical USD 348M 161M 2025-12
Novartis USD 5.14B 392M 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Silence Therapeutics USD -12.46M 13.78M 2025-12